IDXX · IDEXX Laboratories, Inc.

S&P 500 #250 · NASDAQ-100 #77 · Nasdaq

Risiko 6/10 · High-quality compounder / post-selloff · $569.54 ▲ 2.40%

Kennzahlen

• Price $569.54
• Market cap $44.9B
• P/E (ttm) 41.97
• Div yield none
• 52-wk range $518.55 – $769.98
• Index rank #250 / #77

Wichtigste Risiken

• Pet-care spending slowdown in macro downturn (Revenue growth) — HIGH
• Down ~14% YTD; recovery pace uncertain (Near-term price) — MED
• Premium valuation vs. slower growth (Valuation re-rating) — MED
• Competitive pressure from generics in diagnostics (Margins) — LOW

Fazit

Near-monopoly in veterinary diagnostics; pulled back sharply from ATH on macro concerns but raised 2026 EPS guidance, creating a potential re-entry setup.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.